eMolecules Acquires Frontier Scientific Inc. and Frontier Agricultural Sciences Inc.
September 7, 2022
eMolecules, a PE-backed provider of a chemistry search-and-fulfillment platform, has acquired Frontier Scientific Inc. (FSI) and Frontier Agricultural Sciences Inc. (FAS). The acquisitions expand eMolecules' capabilities in compound/sample management, analytical and procurement services and provide an entry into agricultural chemistry/entomology research markets.
- Buyers
- eMolecules, Inc., Avista Capital Partners
- Targets
- Frontier Scientific Inc., Frontier Agricultural Sciences Inc.
- Industry
- Pharmaceuticals
- Location
- Delaware, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Montrose Environmental Group Acquires Frontier Analytical Laboratories
January 6, 2023
Environmental Services
Montrose Environmental Group, Inc. (NYSE: MEG) has acquired Frontier Analytical Laboratories, an El Dorado Hills, California-based environmental laboratory specializing in high-resolution GC‑MS analysis of dioxins, furans, PCBs and other persistent organic pollutants. Frontier will be integrated into Montrose’s Measurement and Analysis segment and operate as part of Enthalpy Analytical, LLC; Frontier’s leadership team will join Montrose. Terms were not disclosed.
-
Evoqua Water Technologies Acquires Frontier Water Systems
April 4, 2022
Environmental Services
Evoqua Water Technologies purchased the remaining equity of San Diego-based Frontier Water Systems, completing its acquisition after an initial majority investment in 2019. Frontier, a supplier of modular bioreactor engineered equipment for removal of selenium, nitrate and metals from industrial wastewater, will expand Evoqua’s advanced wastewater treatment capabilities; terms were not disclosed.
-
Avista Capital Partners Invests in eMolecules
March 25, 2021
Healthcare Services
Avista Capital Partners has signed a definitive agreement to invest in eMolecules, a San Diego–based e-procurement and marketplace platform for high-value chemicals and bioreagents used in drug discovery. Financial terms were not disclosed; Avista said the investment will support eMolecules' growth and expansion into additional biopharma and academic customers.
-
Frontage Laboratories Acquires Concord Biosciences
April 5, 2018
Healthcare Services
Frontage Laboratories Inc., a global contract research organization based in Exton, Pennsylvania, acquired Concord Biosciences (formerly Ricerca Biosciences), a preclinical CRO near Cleveland, Ohio. The acquisition adds Concord’s preclinical, toxicology, bioanalytical and agrochemical testing capabilities to Frontage’s early-stage product development services, broadening its service offering across pharmaceutical, agricultural and animal health markets.
-
Deveron Corp. Acquires Assets of Frontier Labs Inc.
November 1, 2022
Agriculture
Deveron Corp. (TSXV: FARM) has acquired all assets of Frontier Labs Inc., a soil laboratory and agronomy services provider serving Iowa and Minnesota. The asset purchase included an initial US$825,000 cash payment, milestone cash/share payments and issued common shares as part of consideration, expanding Deveron’s lab and agronomy capabilities in the U.S. Midwest.
-
eMolecules Acquires Synple Chem AG
September 24, 2024
Biotechnology
eMolecules, a San Diego-based provider of a chemical compound search-and-fulfillment platform and a portfolio company of Avista Healthcare Partners, has acquired Synple Chem AG, an automated chemical synthesis systems and services provider headquartered near Zurich, Switzerland. The acquisition adds Synple's automation technology and a virtual compound library of more than 7 trillion tractable compounds to eMolecules' existing offering, expanding its capabilities as a one-stop shop for compound procurement, management and automation for drug discovery customers.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.